## Abstract ## OBJECTIVES: Guidelines recommend pharmacologic prophylaxis for hospitalized medical patients at increased risk of thromboembolism. Despite recommendations, multiple studies demonstrate underutilization. Factors contributing to underutilization include uncertainty that prophylaxis re
Stress-ulcer prophylaxis for general medical patients: A review of the evidence
β Scribed by Todd Janicki; Scott Stewart
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 103 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1553-5592
- DOI
- 10.1002/jhm.177
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Gastric stress ulceration and bleeding are common occurrences in the critically ill and prophylactic acidβsuppression is used almost universally in this population. Evidence suggests that general medical patients hospitalized outside of the intensive care unit often receive similar therapy.
PURPOSE
To determine how frequently general medical patients are prescribed stress ulcer prophylaxis and what evidence exists for doing so.
DATA SOURCE
The MEDLINE database (1966 to October 2005), the Cochrane Central Register of Controlled Trials (4th Quarter 2005), and the bibliographies of selected articles.
STUDY SELECTION
Studies that contained significant data about either the frequency of use of stress ulcer prophylaxis in general medical patients or gastrointestinal bleeding outcomes in patients given prophylaxis.
DATA EXTRACTION
The primary author extracted prevalence and outcome data.
DATA SYNTHESIS
Descriptive studies suggest that 20β25% of general medical patients receive acid suppression for stress ulcer prophylaxis in the absence of presumed (but not established) risk factors for bleeding. Only two randomized, controlled trials evaluated the effects of prophylaxis in this population. The first found a reduction in clinically significant gastrointestinal bleeding from 6% (3 of 48) with placebo to zero (n = 52) with magaldrate. The second found a reduction in clinically significant bleeding from 3% (2 of 70) with sucralfate to zero (n = 74) with cimetidine.
CONCLUSION
A significant number of general medical patients are prescribed acidβsuppressive therapy for stress ulcer prophylaxis. The literature provides only sparse guidance on this issue with two randomized trials showing a possible benefit for prophylaxis. Further study is needed. Journal of Hospital Medicine 2007;2:86β92. Β© 2007 Society of Hospital Medicine.
π SIMILAR VOLUMES